AMBER WALKER: Open Payments
NPI 1811448202 · BOAZ, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 11 payments from 8 companies in 2025. Trend: 2023 $554 · 2024 $677 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 3 | $53 |
| ABBVIE INC. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $26 |
| Ardelyx, Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
Products named: VOQUEZNA, MAVYRET, UZEDY, IBSRELA, General - Pain Management, ENTYVIO, DUPIXENT.
Industry payments across AL — which companies pay providers there.
